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bidity and mortality. Surgical techniques have recently improved. We review
here a single-center experience in mitral valve (MV) surgery for CMVS.
Patients: Between 1975 and 2013, 50 pts underwent MV surgery for
CMVS. Six (12%) were adults (>18 yrs) and 18 were <2 yrs (36%). Median
age was 3 yrs (19 d-30 yrs, mean 6.3 yrs), median weight 13kg (2.7-80kg,
mean 19.2kg). In 35 pts, CMVS was part of left heart obstructive syndrome,
with 1 or more previous non-MV surgery in 25. Among the 15 pts with “iso-
lated” CMVS, 2 had previous non-MV surgery. Two pts had previous mitral
valvuloplasty in another center.
Results: First choice MV surgery was valvuloplasty in 48 pts, prosthetic
valve replacement (MVR) in 2. In the valvuloplasty group, 14 pts were
reoperated with a median delay of 11mo (mean 22mo, 19 d-16.6 yrs). Second
surgery was MVR in 3, valvuloplasty in 11. Five pts had a 3rd surgery
(3 MVR, 3 valvuloplasty), 2 had a 4th surgery (redo MVR). There were
6 deaths (overall mortality 12%): 2 after first surgery (1 valvuloplasty, 1
MVR, respectively 8 and 14 days postop), 4 after the second surgery (24 days
and 3.5mo after valvuloplasty, 30 days and 31 yrs after MVR). Risk factors
for postoperative death were: presence of supravalvular lesions (left superior
vena cava in the coronary sinus and/or supramitral ring, p<0.04), surgery for
supravalvular lesions (p<0.04), longer cardiac bypass time (p<0.03) and
longer ICU stay duration (p<0.01). Risk factors for reoperation were younger
age (p=0.008) and low weight (p<0.04) at first surgery. 
Conclusion: Valvuloplasty as first-choice surgery for CMVS carries an
acceptable initial mortality but a relatively high rate of reoperations (29%).
Iterative plasty is possible but mortality is higher (18%). 
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Objectives: To assess health-related quality of life (QoL) in patients with
pulmonary arterial hypertension associated with congenital heart disease
(PAH-CHD) and correlations with clinical status.
Methods: This cross-sectional study included PAH-CHD patients in 14
centers in France. QoL was self-reported with a generic questionnaire (SF-36)
and a PH-specific questionnaire (CAMPHOR). Patients filled out the Hospital
Anxiety and Depression Scale (HADS) questionnaire. Main clinical data were
collected.
Results: 200 patients were included (mean age 43±SD15.7 years, range 15
to 86 years, 70% female), and were classified as Eisenmenger syndromes
(73.5%), PAH associated with systemic to pulmonary shunts (13%), PAH
associated with small defects (3.5%) and PAH after corrective cardiac surgery
(10%). At inclusion, 76.5% patients were receiving PAH-specific treatments.
All component scores of both QoL questionnaires showed degradation vs
healthy population standard scores. QoL scores were lower in females than in
males for all dimensions of both questionnaires (p<0.05). QoL scores were
independent of the type of PAH-CHD but significantly depended on NYHA
class even after gender adjustment. In a multivariate analysis, variables signif-
icantly affecting QoL included NYHA class, six-minute walk distance,
HADS, gender, recent stressful event, and more than one hospitalization
within the past 12 months. 
Conclusion: This study showed degradation of QoL in a large cohort of
PAH-CHD patients with both generic and specific questionnaires. QoL was
correlated with NYHA class but not with the type of PAH-CHD.
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Background: Survival is improved in pulmonary arterial hypertension
(PAH) associated with congenital heart disease (CHD) patients and is related
to right ventricular (RV) function. In this study we aimed to investigate the
prognostic role of RV mechanics in Eisenmenger Syndrome (ES) compared
with other causes of PAH using speckle-tracking imaging.
Methods and Results: We performed a prospective cohort study. We
recruited 80 consecutive adult PAH patients: 39 patients with ES and non-
complex CHD (mean age 41,5±15,6 years) and 41 patients with group 1
PAH (mean age 58,9±17,8). Clinical assessment, BNP and echocardiography
were realised at the time of inclusion and then clinical outcomes were col-
lected during the regular follow-up. Normal strain values were obtained
from 37 control volunteers. On inclusion, 53 patients (66.3%) were in func-
tional class III or higher. Mean BNP was lower in ES (p<0,001) but TAPSE
(p=0,6) and peak RV longitudinal strain (p=0,9) were similar in both groups.
Global longitudinal LV strain was midly reduced in ES (–16,2±5 vs –17,9±8%,
p=0,03), whereas no difference was found for circumferential strain. Mean
RV transverse strain was higher in ES patients (27,3±17 vs 14±11%;
p<0,001) but still reduced in comparison with normal values (44,9±16%,
p<0,001). Whereas normal RVs present a base to apex transverse strain
gradient, ES patients more frequently present a predominant apical func-
tion (p<0,001). Over a median follow-up of 20,6 months, 32 patients were
hospitalized for PAH and 16 died from cardio-pulmonary causes. On
multivariate survival analysis (including age, NYHA class and advanced
therapies), peak transverse strain (HR 0.92 [0.87-0.98]) and CHD (HR
0.17 [0.05-0.6]) were associated and were the strongest predictors of
event-free survival.
Conclusion: The increased RV transverse strain and predominant apical
function in ES could explain their survival advantage as transverse strain is a
strong independent predictor of outcomes in PAH. 
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Isolated proximal anomalous connections of the coronary arteries
(ANOCOR) are rare and sometimes raise diagnostic and therapeutic problems.
The prognosis depends mainly on the initial course of the ectopic vessel. In
the current guidelines, surgical repair is recommanded for high risk
ANOCOR. The lack of controlled studies and scarcity of data concerning the
long-term evaluation of ANOCOR corrected or not may explain the discor-
dance noticed between recommandations and practices. Large-scale prospec-
tive multicenter registries dedicated to ANOCOR are needed to achieve a
better understanding of the clinical profile and the impact of correction on the
natural history of these congenital coronary abnormalities.
The ANOCOR study began 31st January, 2010 with an inclusion period of
3 years. More than 450 young people (≥15-year-old) and adults have been included
by 71 interventional cardiologists from the Interventional Working Group (GACI)
of the French Society of Cardiology. A 5-years follow-up was scheduled.
Clinical characteristics, angiographic patterns and computed tomography
images, as well as the initial management of the ANOCOR cohort patients
will be presented. 
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Stents have contributed to the development of the interventional catheter-
ization of congenital heart diseases (CHD). The aim of this study was to
describe current indications and results.
Methods: Participation to this study was proposed to all catheterization
laboratories specialized in CHD in France (M3C network). All cases with
stents implantation in 2013 in pediatric and adult CHD were retrospectively
included. Adverse events were assessed using the Bergersen classification.
Risk markers were searched using univariate and multivariate analysis. 
Results: 174 stents were implanted in 127 patients. Patients were aged
15.7±15.1 year old (min 5 day-old – max 70 year-old). Main indications were
transcatheter pulmonary valve replacement (prestenting and revalvulation;
n=29 patients, 23.0%), pulmonary artery branches angioplasty (n=34, 27.0%),
aortic coarctation or recoarctation stenting (n=37, 29.4%) and ductus arteri-
osus stenting (n=11, 8.7%). 18 Patients (14.3%) were under one-year old and
35 (27.8%) were over 18 year-old. Main pathologies were tetralogy of Fallot
and variants (ACC-CHD 8.3, n=45, 35.7%), and aortic coarctation (ACC-
CHD 9.2, n=36, 28.6%). More than one stent was implanted in 32 procedures
(24.4%, max. 5 stents). Main stents implanted were the CP stent (33.0%), EV3
LD max (22.0%), Valeo (16.2%) and valved stents (15.0%). 98.5% Proce-
dures were considered as successful. Adverse events were observed in 16.7%
procedures (stent related in 12.1% procedures). Serious adverse events were
observed in 12.9%. After uni- and multivariate adjustment, only procedure
type was related to the risk of total adverse events but not to stent related
adverse events. Age, weight, center, type of stents, genetic disorder and type
of CHD were not significantly related to the risk of adverse events.
Conclusion: Stents are used in various CHD catheterization procedures,
from infancy to adult age. Adverse events rate is significant and seems related
to the type of procedure.
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Objectives: To evaluate and compare the incidence, clinical presentations
and outcomes of right-sided infective endocarditis in patients with surgical
pulmonary conduit versus those with percutaneous pulmonary valve implanta-
tion.
Methods: All consecutive patients who received a pulmonary valve surgi-
cally or percutaneously between January 2009 and June 2013 were included
and evaluated for endocarditis. 
Results: Of the 195 conduits surgically implanted (surgical group) and 93
Melody valves percutaneously implanted (PPVI group), the person-time inci-
dence rates of endocarditis were 1.2 and 3.9 cases per 100 person-years in the
surgical and PPVI groups respectively (p=0.03). Clinical presentations, micro-
biology and outcomes were comparable in both groups. The implantation-
endocarditis time interval was much shorter in the Melody valve patients
(p=0.0065). On multivariate analysis, only a past history of endocarditis was
found to significantly correlate with endocarditis (p=0.004). Probability of sur-
vival at 12, 24 and 36 months was 99.5%, 93.8%, 93.8% in the surgical-group
and 98.9%, 96.8%, 92.3% in the Melody-group respectively (p=0.6). Event
free probability including endocarditis was comparable (p=0.1). 
Conclusion: There is a high person-time incidence of endocarditis in
patients with Melody valve when compared to surgically implanted pulmonary
valves. Clinical features and microbiology were comparable in both groups.
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